Effect of oral contraceptives on vascular endothelial growth factor, Cox-2 and aromatase expression in the endometrium of uteri affected by myomas and associated pathologies

Contraception

Volumn 78, Issue 6, 2008, Pages 479-485

  Maia Jr , Hugo ^a,b   Casoy, Julio ^a   Pimentel, Kleber ^b   Correia, Tania ^c,d   Athayde, Célia ^a   Cruz, Thomaz ^b   Coutinho, Elsimar Metzker ^a  

^a Centro De Pesquisa E Assistencia Em Reproducao Humana   (Brazil)

^b FEDERAL UNIVERSITY OF BAHIA   (Brazil)

^c ESCOLA BAHIANA DE MEDICINA E SAÚDE PÚBLICA   (Brazil)

^d INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

Aromatase; Cox 2; Gestodene; Menorrhagia; Myoma; VEGF

Indexed keywords

AROMATASE; CYCLOOXYGENASE 2; ETHINYLESTRADIOL PLUS GESTODENE; GESTINOL; ORAL CONTRACEPTIVE AGENT; PROGESTERONE; UNCLASSIFIED DRUG; VASCULOTROPIN;

ADENOMYOSIS; ADULT; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; DRUG UTILIZATION; ENDOMETRIOSIS; ENDOMETRIUM; ENDOMETRIUM POLYP; FEMALE; FISHER EXACT TEST; HUMAN; HUMAN TISSUE; HYSTEROSCOPY; IMMUNOHISTOCHEMISTRY; LUTEAL PHASE; MAJOR CLINICAL STUDY; MENORRHAGIA; MENSTRUAL CYCLE; PROLIFERATIVE PHASE; PROTEIN EXPRESSION; RANK SUM TEST; UTERUS DISEASE; UTERUS MYOMA;

ADULT; AROMATASE; CONTRACEPTIVES, ORAL; CYCLOOXYGENASE 2; ENDOMETRIUM; FEMALE; HUMANS; HYSTERECTOMY; IMMUNOHISTOCHEMISTRY; LUTEAL PHASE; MENORRHAGIA; PROGESTERONE; UTERINE NEOPLASMS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 55949089368     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.contraception.2008.07.002     Document Type: Article

References (28)

1. Orsini G., Laricchia L., and Fanelli M. Low dose combination oral contraceptive use in women with uterine leiomyomas. Minerva Ginecol 54 (2002) 253-261
2. Maia Jr. H., Pimentel K., Casoy J., et al. Aromatase expression in the eutopic endometrium of myomatous uteri: the influence of the menstrual cycle and oral contraceptive use. Gynecol Endocrinol 23 (2007) 320-324
3. Fechner S., Husen B., Thole H., et al. Expression and regulation of estrogen-converting enzymes in ectopic human endometrial tissue. Fertil Steril 88 4 Suppl (2007) 1029-1038
4. Soysal S., and Soysal M.E. The efficacy of levonorgestrel-releasing intrauterine device in selected cases of myoma-related menorrhagia: a prospective controlled trial. Gynecol Obstet Invest 1 (2005) 5929-5935
5. Laoag-Fernandez J.B., Maruo T., Pakarinen P., Spitz I.M., and Johansson E. Effects of levonorgestrel-releasing intra-uterine system on the expression of vascular endothelial growth factor and adrenomedullin in the endometrium in adenomyosis. Hum Reprod (2003) 18694-18699
6. Maia Jr. H., and Casoy J. Non-contraceptive health benefits of oral contraceptives. Eur J Contracept Reprod Health Care 13 (2008) 17-24
7. Charnock Jones D.S., Hharkey A.M., Rajput-Williams J., et al. Identification and localization of alternately spliced mRNAs for vascular endothelial growth factor in human uterus and estrogen regulation in endometrial carcinoma cell lines. Bull Reprod 48 (1993) 1120-1128
8. Classen-Linke I., Alfer J., Krusche C.A., Chwalisz K., Rath W., and Beier H.M. Progestins, progesterone receptor modulators and progesterone antagonists change VEGF release of endometrial cells in culture. Steroids 65 (2000) 763-771
9. Nayak N.R., and Brenner R.M. Vascular proliferation and vascular endothelium growth factor expression in the rhesus macaque endometrium. J. Clin Endocrinol Metab 87 (2002) 1845-1855
10. Mints M., Blomgren B., Falconer C., Fianu-Jonasson A., and Palmblad J. Microvascular density, vascular endothelial growth factor A, and its receptors in endometrial blood vessels in patients with menorrhagia. Fertil Steril 84 (2005) 692-700
11. Smith O.P., Jabbour H.N., and Critchley H.O. Cyclooxygenase enzyme expression and E series prostaglandin receptor signaling are enhanced in heavy menstruation. Hum Reprod 22 (2007) 1450-1456
12. Maia Jr. H., Maltez A., Studart E., Zausner B., Athayde C., and Coutinho E. Effect of the menstrual cycle and oral contraceptives on cyclooxygenase-2 expression in the endometrium. Gynecol Endocrinol 21 (2005) 57-61
13. Modugno F., Ness R.B., Chen C., and Weiss N.S. Inflammation and endometrial cancer: a hypothesis. Cancer Epidemiol Biomarkers Prev 14 (2005) 2840-2847
14. Maia Jr. H., Maltez A., Coelho G., Athayde C., and Coutinho E.M. Insertion of Mirena after endometrial resection in patients with adenomyosis. J Am Assoc Gynecol Laparosc 10 (2003) 512-516
15. Hervé M.A., Meduri G., Petit F.G., et al. Regulation of the vascular endothelial growth factor (VEGF) receptor Flk-1/KDR by estradiol through VEGF in uterus. J Endocrinol 188 (2006) 91-99
16. Albrecht E.D., and Pepe G.J. Steroid hormone regulation of angiogenesis in the primate endometrium. Front Biosci 8 (2003) 416-429
17. Hague S., Zhang L., Oehler M.K., et al. Expression of the hypoxically regulated angiogenic factor adrenomedullin correlates with uterine leiomyoma vascular density. Clin Cancer Res 6 (2000) 2808-2814
18. Heryanto B., Lipson K.E., and Rogers P.A. Effect of angiogenesis inhibitors on oestrogen-mediated endometrial endothelial cell proliferation in the ovariectomized mouse. Reproduction 125 (2003) 337-346
19. Okolo S.O., Gentry C.C., Perrett C.W., and Maclean A.B. Familial prevalence of uterine fibroids is associated with distinct clinical and molecular features. Hum Reprod 20 (2005) 2321-2324
20. Attar E. Aromatase and other steroidogenic genes in endometriosis. Translational aspects. Hum Reprod Update 12 (2006) 49-56
21. Noble L.S. Prostaglandin E2 stimulates aromatase activity in endometriosis derived stromal cells. J Clin Endocrinol Metab 82 (1997) 600-606
22. Bulum S.E., Gurates B., Fang Z., et al. Mechanisms of excessive estrogen formation in endometriosis. J Reprod Immunol 55 (2002) 21-33
23. Maia Jr. H., Casoy J., Correia T., et al. Effect of the menstrual cycle and oral contraceptives on aromatase and cyclooxygenase-2 expression in adenomyosis. Gynaecol Endocrinol 22 (2006) 1-5
24. Maia Jr. H., Pimentel K., and Silva T.M. Aromatase and cyclooxygenase-2 expression in endometrial polyps during the menstrual cycle. Gynecol Endocrinol 22 (2006) 219-224
25. Miura S., Khan K.N., Kitajima M., et al. Differential infiltration of macrophages and prostaglandin production by different uterine leiomyomas. Hum Reprod 21 (2006) 2545-2554
26. Tamura M., Deb S., Sebastian S., Okamura K., and Bulun S.E. Estrogen up-regulates cyclooxygenase-2 via estrogen receptor in human uterine microvascular endothelial cells. Fertil Steril 81 (2004) 1351-1356
27. Sugino N., Karube-Harada A., Taketani T., Sakata A., and Nakamura Y. Withdrawal of ovarian steroids stimulates prostaglandin F2alpha production through nuclear factor-kappaB activation via oxygen radicals in human endometrial stromal cells: potential relevance to menstruation. J Reprod Dev 50 (2004) 215-225
28. Han M., Kim J.Y., Park J.E., Kim J.M., and Lee K.S. Effects of letrozole on proliferation and apoptosis in cultured leiomyoma cells treated with prostaglandin E(2). Eur J Obstet Gynecol Reprod Biol. 138 (2008) 83-88